94 related articles for article (PubMed ID: 26403739)
1. [MicroRNA-133a antagonizes phenylephrine-induced hypertrophy of neonatal rat cardiomyocytes in vitro].
Li Q; Yang X; Zhou X; Xiao L; Lin X; Zhang F; Li L; Yu Y; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1283-6. PubMed ID: 26403739
[TBL] [Abstract][Full Text] [Related]
2. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
Wu Y; Wang YQ; Wang BX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2.
Li S; Xiao FY; Shan PR; Su L; Chen DL; Ding JY; Wang ZQ
J Hum Genet; 2015 Nov; 60(11):709-16. PubMed ID: 26334104
[TBL] [Abstract][Full Text] [Related]
5. SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.
Zhao ZH; Luo J; Li HX; Wang SH; Li XM
Mol Cell Biochem; 2018 Jun; 443(1-2):47-56. PubMed ID: 29110214
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
8. [Effect of miRNA-199a on rat cardiac hypertrophy].
Xu XD; Song XW; Jing Q; Qin YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):446-50. PubMed ID: 21781601
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
Matkovich SJ; Wang W; Tu Y; Eschenbacher WH; Dorn LE; Condorelli G; Diwan A; Nerbonne JM; Dorn GW
Circ Res; 2010 Jan; 106(1):166-75. PubMed ID: 19893015
[TBL] [Abstract][Full Text] [Related]
11. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
Li Q; Lin X; Yang X; Chang J
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1340-7. PubMed ID: 20173049
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a.
Liu J; Hao DD; Zhang JS; Zhu YC
Biochem Biophys Res Commun; 2011 Sep; 413(2):342-7. PubMed ID: 21893044
[TBL] [Abstract][Full Text] [Related]
13. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a.
Hua Y; Zhang Y; Ren J
J Cell Mol Med; 2012 Jan; 16(1):83-95. PubMed ID: 21418519
[TBL] [Abstract][Full Text] [Related]
15. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes.
Kesherwani V; Nandi SS; Sharawat SK; Shahshahan HR; Mishra PK
Mol Cell Biochem; 2015 Jun; 404(1-2):241-50. PubMed ID: 25763715
[TBL] [Abstract][Full Text] [Related]
17. Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation.
Huang L; Xi Z; Wang C; Zhang Y; Yang Z; Zhang S; Chen Y; Zuo Z
Sci Rep; 2016 Feb; 6():20105. PubMed ID: 26830171
[TBL] [Abstract][Full Text] [Related]
18. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
Duan Y; Zhou B; Su H; Liu Y; Du C
Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
[TBL] [Abstract][Full Text] [Related]
19. Transfection by eukaryotic expression vector pcDNA3-HERG inhibits the cultured neonatal rabbit ventricular myocyte hypertrophy induced by phenylephrine.
Zhao Y; Xu Y; Cui C; Li Y; Zeng Y
Cardiovasc Pathol; 2012; 21(4):339-45. PubMed ID: 22100990
[TBL] [Abstract][Full Text] [Related]
20. miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2.
Yuan J; Yuan G
Mediators Inflamm; 2022; 2022():5187218. PubMed ID: 36060928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
